Business News›Mutual Funds›ICICI Prudential Mutual Fund › ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth
ICICI Prudential Pharma Healthcare and Diagnostics...
(Scheme Rating)
NAV as of Oct 17, 2025
40.400.17%
- Growth - Regular
(Earn upto 0.84% Extra Returns with Direct Plan)
Fund Category:
Equity: Sectoral-Pharma
Expense Ratio:
1.87%(1.54% Category
average)Fund Size:
Rs. 6,226.82 Cr(18.55% of Investment in Category)
- ADD TO PORTFOLIO
Loading...
ADD TO PORTFOLIO
ICICI Prudential Pharma Healthcare and Diagnostics (P.H....
(Scheme Rating)
NAV as of Oct 17, 2025
40.400.17%
Expense Ratio:
1.87%
Fund Size:
Rs. 6,226.82 Cr
Fund Category:
Equity: Sectoral-Pharma
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth Fund Key Highlights
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund as of Oct 17, 2025 is Rs 40.40 for Growth option of its Regular plan.
2. Returns: Its trailing returns over different time periods are: 4.06% (1yr), 27.9% (3yr), 20.0% (5yr) and 21.26% (since launch). Whereas, Category returns for the same time duration are: 0.05% (1yr), 22.37% (3yr) and 16.98% (5yr).
3. Fund Size: The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund currently holds Assets under Management worth of Rs 6226.82 crore as on Sep 30, 2025.
4. Expense ratio: The expense ratio of the fund is 1.87% for Regular plan as on Oct 09, 2025.
5. Exit Load: ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund shall attract an Exit Load, "Exit load of 1% if redeemed within 15 days."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund as of Oct 17, 2025 is Rs 40.40 for Growth option of its Regular plan.
2. Returns: Its trailing returns over different time periods are: 4.06% (1yr), 27.9% (3yr), 20.0% (5yr) and 21.26% (since launch). Whereas, Category returns for the same time duration are: 0.05% (1yr), 22.37% (3yr) and 16.98% (5yr).
3. Fund Size: The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund currently holds Assets under Management worth of Rs 6226.82 crore as on Sep 30, 2025.
4. Expense ratio: The expense ratio of the fund is 1.87% for Regular plan as on Oct 09, 2025.
5. Exit Load: ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund shall attract an Exit Load, "Exit load of 1% if redeemed within 15 days."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth Returns
Trailing Returns
Rolling Returns
Discrete Period
SIP Returns
1M 3M 6M 1Y 3Y 5Y Annualized Returns -0.59 -0.76 10.59 3.86 28.02 20.31 Category Avg 0.20 -0.95 7.62 0.47 22.95 17.45 Rank within Category 21 12 2 5 1 1 No. of funds within Category 28 28 26 23 15 9 - Loading...
- Loading...
Return Comparison
- This Fund
- BenchmarkS&P BSE Sensex
Choose from Benchmarks
- Nifty 50
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth Fund Details
Investment Objective - The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
| Fund House | ICICI Prudential Mutual Fund |
| Launch Date | Jul 13, 2018 |
| Benchmark | |
| Return Since Launch | 21.18% |
| Riskometer | Very High |
| Type | Open-ended |
| Risk Grade | Below Average |
| Return Grade | High |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth Investment Details
| Minimum Investment (Rs.) | 5,000.00 |
| Minimum Additional Investment (Rs.) | 1,000.00 |
| Minimum SIP Investment (Rs.) | 100.00 |
| Minimum Withdrawal (Rs.) | 1.00 |
| Exit Load Exit load of 1% if redeemed within 15 days. | |
Portfolio Allocation
Asset Allocation
Loading...
Asset Allocation History
Loading...
EquityDebtCash
Sector Allocation
Loading...
Market Cap Allocation
Loading...
Concentration & Valuation Analysis
| SEP 2025 | AUG 2025 | JUL 2025 | JUN 2025 | MAY 2025 | APR 2025 | |
|---|---|---|---|---|---|---|
| Number of Holdings | 41 | 37 | 36 | 34 | 38 | 41 |
| Top 5 Company Holdings | 44.6% | 44.33% | 41.92% | 43.91% | 45.54% | 46.22% |
| Top 10 Company Holdings | 63.11% | 63.36% | 61.58% | 64.5% | 64.06% | 64.66% |
| Company with Highest Exposure | Sun Pharmaceutical Industries (11.58%) | Sun Pharmaceutical Industries (11.71%) | Sun Pharmaceutical Industries (11.69%) | Sun Pharmaceutical Industries (12.23%) | Sun Pharmaceutical Industries (12.66%) | Sun Pharmaceutical Industries (13.23%) |
| Number of Sectors | 4 | 4 | 4 | 4 | 4 | 5 |
| Top 3 Sector Holdings | 96.46% | 94.78% | 94.82% | 95.37% | 95.71% | 94.84% |
| Top 5 Sector Holdings | 97.55% | 95.88% | 95.89% | 96.45% | 96.98% | 96.34% |
| Sector with Highest Exposure | Healthcare (92.19%) | Healthcare (90.21%) | Healthcare (89.71%) | Healthcare (89.82%) | Healthcare (89.22%) | Healthcare (89.01%) |
Top Stock Holdings
Sector Holdings in MF
Company Sector Assest(%) P/E EPS-TTM(₹) RETURN 1 YR(%) Sun Pharmaceutical Industries Healthcare 11.58 38.89 43.23 -12.08 Dr. Reddy's Laboratories Healthcare 9.1 18.45 68.07 -6.95 Divi's Laboratories Healthcare 8.75 76.23 86.87 9.95 Aurobindo Pharma Healthcare 8.25 18.86 58.39 -25.19 Cipla Healthcare 6.92 23.64 66.76 1.70 Lupin Healthcare 5.43 23.90 80.99 -10.91 Alkem Laboratories Healthcare 4.05 29.26 191.07 -8.99 Biocon Healthcare 3.11 123.28 2.88 4.80 Gland Pharma Healthcare 2.97 41.45 46.75 17.44 Mankind Pharma Healthcare 2.95 54.01 45.86 -6.44
Peer Comparison
Cumulative Returns
SIP returns
Discrete Returns
Quant Measures
Asset Allocation
Scheme Name NAV(Rs./Unit) Scheme Rating AUM(Rs. Cr) 1M 1Y 3Y 5Y ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth 40.40 6,226.82 -0.59 3.86 28.02 20.31 SBI Healthcare Opportunities Fund-Growth 438.46 3,933.26 1.09 4.57 26.06 19.48 UTI Healthcare Fund Regular Plan-Growth 292.92 1,096.95 -1.04 1.95 24.91 17.55 DSP Healthcare Fund Regular - Growth 39.27 3,074.18 -1.02 -4.65 23.14 17.36 Nippon India Pharma Fund-Growth 513.75 8,113.59 -0.91 -1.62 22.08 17.44
Risk Ratios
Ratios are calculated using the calendar month returns for the last 3 years
Standard Deviation
Standard Deviation
Standard deviation is the deviation of the fund's return around mean.
Moderate Volatility
15.66VS15.66Fund Vs Category Avg
Beta
Beta
Beta shows the portfolio risk in relation to the market. A beta of less than 1 means that the fund returns are less volatile compared to the broader market. A beta of more than 1 means that the fund returns are more volatile than the broader markets. A beta equal to 1 means that fund's volatility is in line with the broader market.
High Volatality
0.95VS0.94Fund Vs Category Avg
Sharpe Ratio
Sharpe Ratio
Sharpe ratio is a risk adjusted performance measure. A fund with a higher Sharpe ratio is considered better than a fund with a lower Sharpe ratio.
Better risk-adjusted returns
1.20VS0.91Fund Vs Category Avg
Treynor's Ratio
Treynor's Ratio
Treynor is a risk adjusted performance measure. A fund with a higher Treynor ratio is considered better than a fund with a lower Treynor ratio.
Better risk-adjusted returns
19.81VS15.27Fund Vs Category Avg
Jensen's Alpha
Jensen's Alpha
Alpha shows the ability of the fund manager to outperform the market. A higher Alpha is preferred.
Better risk-adjusted returns
3.44VS-0.94Fund Vs Category Avg
Mean Return
Mean Return
Average return generated by the fund during a specified period.
Better average monthly returns
25.05VS20.55Fund Vs Category Avg
Risk Ratio Chart
Loading...
- Risk Ratio
- Category Average
Size of Bubbles represents the Fund Size
ICICI Prudential Mutual Fund News
- ICICI Prudential Mutual Fund: RIL and Sun Pharma among top 10 stock holdings in September
- 5 mutual funds added 13 new smallcap stocks in their portfolios in September
- Celebrate the spirit of Dhanteras with smart gold investing
- SBI MF and PPFAS MF among 5 mutual funds that had over Rs 10,000 crore cash in their portfolio in September
Fund Manager
- D.K.Dharmesh KakkadSince May 20208 schemes
Mr. kakkad is B.com., CA & CFA. He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y ICICI Prudential Equity Savings Fund-Growth Equity Savings 22.96 16,487.15 6.94 ICICI Prudential Value Fund-Growth Value Oriented 480.98 55,444.54 4.76 ICICI Prudential India Equity FOF - Growth Flexi Cap 31.25 228.68 1.97 ICICI Prudential Asset Allocator Fund (FOF) - Growth Multi Asset Allocation 122.96 27,750.45 7.53 ICICI Prudential Passive Strategy Fund (FOF)- Growth Flexi Cap 166.64 199.72 4.03 ICICI Prudential Passive Multi-Asset FoF - Growth Multi Asset Allocation 15.76 1,228.89 12.50 ICICI Prudential Global Advantage Fund (FOF)- Growth International 19.20 Unrated 366.89 22.21 ICICI Prudential Thematic Advantage Fund (FOF)- Growth Thematic 228.97 Unrated 6,756.38 4.83
More ICICI Prudential Mutual Fund
| Scheme Name | Rating | Asset Size(Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Large Cap Fund-Growth | 71,787.87 | 0.80 | 1.16 | 12.84 | 0.12 | 17.79 | |
| ICICI Prudential Balanced Advantage-Growth | 64,964.03 | 1.39 | 2.22 | 10.30 | 5.74 | 12.93 | |
| ICICI Prudential Multi Asset Fund-Growth | 63,001.13 | 1.83 | 2.13 | 10.04 | 7.65 | 19.24 | |
| ICICI Prudential Value Fund-Growth | 53,715.52 | 0.85 | 1.08 | 12.22 | 0.01 | 21.31 | |
| ICICI Prudential Liquid Fund-Growth | 51,593.46 | 0.47 | 1.44 | 3.29 | 6.88 | 6.96 | |
| ICICI Prudential Equity & Debt Fund -Growth | 44,605.00 | 1.72 | 2.48 | 12.62 | 4.15 | 19.20 | |
| ICICI Prudential Money Market-Growth | 36,942.29 | 0.42 | 1.56 | 4.16 | 7.88 | 7.50 | |
| ICICI Prudential Corporate Bond Fund-Growth | 33,573.85 | 0.08 | 1.02 | 4.56 | 8.30 | 7.79 | |
| ICICI Prudential Equity Arbitrage-Growth | 31,526.24 | 0.35 | 1.43 | 3.30 | 6.74 | 7.02 | |
| ICICI Prudential India Opportunities Fund - Growth | 29,718.06 | 0.28 | -0.03 | 10.97 | -0.68 | 22.16 |
Mutual Fund Tools
Top AMCs
- SBI Mutual Fund
- ICICI Prudential Mutual Fund
- HDFC Mutual Fund
- Nippon India Mutual Fund
- Kotak Mahindra Mutual Fund
- Aditya Birla Sun Life Mutual Fund
- UTI Mutual Fund
- Axis Mutual Fund
- Mirae Asset Mutual Fund
- DSP Mutual Fund
- Tata Mutual Fund
- Bandhan Mutual Fund
- Edelweiss Mutual Fund
- HSBC Mutual Fund
- Invesco Mutual Fund
About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth
1. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Jul 13, 2018.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. "
2. It is benchmarked against null.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 97.55% in equities, 0.0% in debts and 2.45% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 63.11% of the assets, the top 3 sectors constitute around 96.46% of the assets.
3. The fund largely follows a Blend oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
1. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Jul 13, 2018.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. "
2. It is benchmarked against null.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 97.55% in equities, 0.0% in debts and 2.45% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 63.11% of the assets, the top 3 sectors constitute around 96.46% of the assets.
3. The fund largely follows a Blend oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
This Might Catch Your Interest
FAQs about ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth
- Is it safe to invest in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund?As per SEBI’s latest guidelines to calculate risk grades, investment in the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund comes under Very High risk category.
- What is the category of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund?ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund belongs to the Equity : Sectoral-Pharma category of funds.
- How Long should I Invest in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund?The suggested investment horizon of investing into ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is >3 years. The suggested investment horizon is the minimum time required for holding investments in the fund to reduce its downside risk and ensure that the returns become more predictable.
- Who manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund?The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Priyanka Khandelwal (Since Jun 25, 2018) and Dharmesh Kakkad (Since May 02, 2020).
Date Sources: Mutual Funds, ETFs, and NPS data are sourced from Value Research. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.
